BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 26984222)

  • 21. Ground glass opacity on chest CT scans from screening to treatment: A literature review.
    Lin YH; Hsu HS
    J Chin Med Assoc; 2020 Oct; 83(10):887-890. PubMed ID: 32675737
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnosis and treatment of high-risk bilateral lung ground-glass opacity nodules.
    Cheng M; Ding R; Wang S
    Asian J Surg; 2024 Jan; ():. PubMed ID: 38246790
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pulmonary ground-glass opacity (GGO) lesions-large size and a history of lung cancer are risk factors for growth.
    Hiramatsu M; Inagaki T; Inagaki T; Matsui Y; Satoh Y; Okumura S; Ishikawa Y; Miyaoka E; Nakagawa K
    J Thorac Oncol; 2008 Nov; 3(11):1245-50. PubMed ID: 18978558
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CT-guided Hookwire localization before video-assisted thoracoscopic surgery for solitary ground-glass opacity dominant pulmonary nodules: radiologic-pathologic analysis.
    Huang HZ; Wang GZ; Xu LC; Li GD; Wang Y; Wang YH; He XH; Li WT
    Oncotarget; 2017 Dec; 8(64):108118-108129. PubMed ID: 29296228
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Whack-a-mole strategy for multifocal ground glass opacities of the lung.
    Suzuki K
    J Thorac Dis; 2017 Apr; 9(Suppl 3):S201-S207. PubMed ID: 28446985
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The association between baseline clinical-radiological characteristics and growth of pulmonary nodules with ground-glass opacity.
    Kobayashi Y; Sakao Y; Deshpande GA; Fukui T; Mizuno T; Kuroda H; Sakakura N; Usami N; Yatabe Y; Mitsudomi T
    Lung Cancer; 2014 Jan; 83(1):61-6. PubMed ID: 24268684
    [TBL] [Abstract][Full Text] [Related]  

  • 27. GGO nodule volume-preserving nonrigid lung registration using GLCM texture analysis.
    Park S; Kim B; Lee J; Goo JM; Shin YG
    IEEE Trans Biomed Eng; 2011 Oct; 58(10):2885-94. PubMed ID: 21775252
    [TBL] [Abstract][Full Text] [Related]  

  • 28. How should pulmonary nodules be optimally investigated and managed?
    Callister ME; Baldwin DR
    Lung Cancer; 2016 Jan; 91():48-55. PubMed ID: 26711934
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Knowledge mapping visualization of the pulmonary ground-glass opacity published in the web of science.
    Li X; Zhang G; Gao S; Xue Q; He J
    Front Oncol; 2022; 12():1075350. PubMed ID: 36620580
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safe and effective minimally invasive approaches for small ground glass opacity.
    Kohno T; Fujimori S; Kishi K; Fujii T
    Ann Thorac Surg; 2010 Jun; 89(6):S2114-7. PubMed ID: 20493993
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical relevance of ground glass opacity in 105 patients with miliary tuberculosis.
    Lee J; Lim JK; Seo H; Lee SY; Choi KJ; Yoo SS; Lee SY; Cha SI; Park JY; Kim CH
    Respir Med; 2014 Jun; 108(6):924-30. PubMed ID: 24787005
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recommendations for the management of subsolid pulmonary nodules detected at CT: a statement from the Fleischner Society.
    Naidich DP; Bankier AA; MacMahon H; Schaefer-Prokop CM; Pistolesi M; Goo JM; Macchiarini P; Crapo JD; Herold CJ; Austin JH; Travis WD
    Radiology; 2013 Jan; 266(1):304-17. PubMed ID: 23070270
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Should sublobar resection be offered for screening-detected lung nodules?
    Sihoe ADL
    Transl Lung Cancer Res; 2021 May; 10(5):2418-2426. PubMed ID: 34164289
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lymphadenectomy is Unnecessary for Pure Ground-Glass Opacity Pulmonary Nodules.
    Lin YH; Chen CK; Hsieh CC; Hsu WH; Wu YC; Hung JJ; Hsu PK; Hsu HS
    J Clin Med; 2020 Mar; 9(3):. PubMed ID: 32131524
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insights for Management of Ground-Glass Opacities From the National Lung Screening Trial.
    Robbins HA; Katki HA; Cheung LC; Landy R; Berg CD
    J Thorac Oncol; 2019 Sep; 14(9):1662-1665. PubMed ID: 31125735
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor blood vessel in 3D reconstruction CT imaging as an risk indicator for growth of pulmonary nodule with ground-glass opacity.
    Xue W; Kong L; Zhang X; Xin Z; Zhao Q; He J; Wu W; Duan G
    J Cardiothorac Surg; 2023 Nov; 18(1):333. PubMed ID: 37968739
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Progressions on Diagnosis and Treatment of Ground-glass Opacity].
    Zhao Y; Wang R; Chen H
    Zhongguo Fei Ai Za Zhi; 2016 Nov; 19(11):773-777. PubMed ID: 27866521
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Prognostic Significance of Pure Ground Glass Opacities in Lung Cancer Computed Tomographic Images.
    Huang C; Wang C; Wang Y; Liu J; Bie F; Wang Y; Du J
    J Cancer; 2019; 10(27):6888-6895. PubMed ID: 31839823
    [No Abstract]   [Full Text] [Related]  

  • 39. Clinical, pathological and radiologic features of minute pulmonary meningothelial-like nodules.
    Wen Z; Zhang Y; Fu F; Ma Z; Deng C; Ma X; Hu H; Sun Y; Chen H
    J Cancer Res Clin Oncol; 2022 Jun; 148(6):1473-1479. PubMed ID: 34287680
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management of pulmonary multifocal ground-glass nodules: How many options do we have?
    Liu B; Ye X
    J Cancer Res Ther; 2020; 16(2):199-202. PubMed ID: 32474501
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.